Sema Zergeroğlu

ORCID: 0000-0003-2348-7379 · 7 papers in corpus
2014
other 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.06.029

OBJECTIVE: To determine the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in the rat endometriosis model. STUDY DESIGN: A randomized, placebo-controlled, blinded study using rat endometriosis model.…

other 2010
Archives of gynecology and obstetrics ·doi:10.1007/s00404-010-1434-0

OBJECTIVE: To show the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in an experimental model. DESIGN: A randomized, placebo-controlled, blinded study using rat endometriosis model. SETTING: Experi…

lab-animal 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.07.1527

The effect of immunomodulator leflunomide on the development of an experimental endometriosis model was assessed by surgically transplanting autologous fragments of endometrial tissue onto the inner surface of the abdominal wall and arteria…

lab-animal 2006
Journal of the Society for Gynecologic Investigation ·doi:10.1016/j.jsgi.2006.03.006

OBJECTIVE: To test if leflunomide, an immunomodulator, could impede the growth of an ectopic uterine tissue. METHODS: Endometriosis was surgically induced in 26 rats by transplanting an autologous fragment of endometrial tissue onto the in…

2002
·doi:10.16948/zktb.45584

Objective : The aim of this study is the correlation of clinical findings, ultrasonographic findings and postlaparoscopic pathological findings of 627 patients who were prediagnosed as endometrioma in the recent one year period in our hospi…

1998
·doi:10.16948/zktb.48919